Riggs Josh

Riggs Josh is listed in filings as CEO and President at Insight Molecular Diagnostics Inc.. This profile follows SEC Form 4 activity through Mar 30, 2026, including 4 public disclosures. Recent filings connect the profile to Insight Molecular Diagnostics Inc. (IMDX). The current snapshot covers public activity from Mar 28, 2025 to Mar 30, 2026. Reported amounts are shown as $1.3M to $50.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.